Bellevue Life Sciences Acquisition Corp. (BLACU) Prices $60M IPO
by Marlena Haddad on 2023-02-09 at 5:55pm

Bellevue Life Sciences Acquisition Corp. priced its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “BLACU” Friday, February 10, 2023.

The new SPAC intends to acquire a target business in the healthcare industry, specifically in the biotechnology sector developing the next generation of biologics. Bellevue Life Sciences is led by CEO Kuk Hyuon Hwang, CFO David J. Yoo, and Nominee for Chairman of the Board Steven Reed.

Total SPAC deal count for 2023 year-to-date is now 4. This offering is expected to close on Tuesday, February 14.


Chardan is acting as the sole book-running manager of the offering. K&L Gates LLP is serving as Issuer’s Counsel with Kirkland & Ellis LLP serving as Underwriter’s Counsel. WithumSmith+Brown, PC serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.

Recent Posts
by Nicholas Alan Clayton on 2025-04-21 at 8:19am

At the SPAC of Dawn This week appears set to start in the red as futures blink negative after a long weekend and the end of Spring Break in the New York area. Four SPACs are nonetheless seeking extensions from shareholders this week, although no SPAC has yet scheduled a deal approval vote for the...

by Kristi Marvin on 2025-04-19 at 10:02am

Terms Tracker for the Week Ending April 18, 2025 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. Six new SPACs filed to IPO this week. That’s not a typo. Six. Plus, another 13 amended S-1/A were filed. The total number of SPACs...

by Kristi Marvin on 2025-04-18 at 8:16am

At the SPAC of Dawn As we close out Passover and head into Easter weekend, we’re reminded that even the most hopeless situations, like wandering the desert for 40 years, being dead for three days, or trying to close a DeSPAC with zero redemptions in this market, can eventually turn around. After all, SPACs have...

by Nicholas Alan Clayton on 2025-04-17 at 4:27pm

Globa Terra Acquisition Corporation (NASDAQ:GTERU) has filed for a $152.2 million SPAC to find an agriculture or food-tech target company The new SPAC is overfunded to 100.5% and is set to have both a 3/4 warrant and right to a 1/20 share in each of its units. This vies for the most investor-friendly unit coverage of...

by Nicholas Alan Clayton on 2025-04-17 at 1:26pm

EGH Acquisition Corp. (NASDAQ:EGHAU) has filed for a $150 million SPAC to continue the work of the Tortoise serial SPAC team under a fresh name. The new SPAC is not overfunded and will have one right to a 1/10 share in each of its units. It will have 24 months to initially close a business...

logo

Copyright © 2025 SPACInsider, Inc. All Rights Reserved